Live Breaking News & Updates on Medicine company profile

Stay informed with the latest breaking news from Medicine company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medicine company profile and stay connected to the pulse of your community

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Robert-nelsen , Sg-americas-securities , Oppenheimer-co , Chelsea-counsel-co , Mirae-asset-global-investments-co , Medicine-inc , Medicine-company-profile , Green-alpha-advisors , Prime-medicine , Get-free-report , Medicine-stock-down

Levin Capital Strategies L.P. Makes New $177,000 Investment in Prime Medicine, Inc. (NYSE:PRME)

Levin Capital Strategies L.P. purchased a new position in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,000 shares of the company’s stock, valued at approximately $177,000. Other hedge funds have also recently modified their holdings of […]

China , Stifel-nicolaus , Robert-nelsen , Medicine-company-profile , Oppenheimer-co , China-universal-asset-management-co , Sg-americas-securities , Profund-advisors , Medicine-inc , Prime-medicine , Free-report , Universal-asset-management

Prime Medicine (NYSE:PRME) Reaches New 12-Month Low at $4.32

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $4.32 and last traded at $4.50, with a volume of 130514 shares traded. The stock had previously closed at $4.70. Wall Street Analyst Weigh In PRME has been the […]

Stifel-nicolaus , Robert-nelsen , Medicine-company-profile , Chelsea-counsel-co , Oppenheimer-co , Green-alpha-advisors , Securities-exchange-commission , Medicine-inc , Sg-americas-securities , Mirae-asset-global-investments-co , Prime-medicine , Get-free-report

Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Robert-nelsen , Vanguard-group-inc , Sumitomo-mitsui-trust-holdings-inc , Medicine-inc , Medicine-company-profile , Pricet-rowe-associates-inc , Securities-exchange-commission , Blackrock-inc , Investment-management , Prime-medicine , Get-free-report

Prime Medicine (NYSE:PRME) Sets New 52-Week Low at $5.48

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low on Friday . The company traded as low as $5.48 and last traded at $5.82, with a volume of 210141 shares traded. The stock had previously closed at $5.79. Wall Street Analysts Forecast Growth A number of research firms have […]

Robert-nelsen , Stifel-nicolaus , Citigroup , Medicine-company-profile , Medicine-inc , Barclays-plc , Greenwich-wealth-management , Rafferty-asset-management , Investment-management , Citigroup-inc , Prime-medicine , Get-free-report

Prime Medicine (NYSE:PRME) Shares Gap Up to $6.87

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.87, but opened at $7.10. Prime Medicine shares last traded at $6.70, with a volume of 113,845 shares changing hands. Analyst Ratings Changes Several equities research analysts have recently issued […]

Canada , Stifel-nicolaus , Robert-nelsen , Sg-americas-securities , Ameritas-investment-partners-inc , Medicine-inc , Life-insurance-co , Chelsea-counsel-co , Citigroup , Medicine-company-profile , Royal-bank , Prime-medicine

Prime Medicine (NYSE:PRME) PT Lowered to $20.00

Prime Medicine (NYSE:PRME) PT Lowered to $20.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robert-nelsen , Stifel-nicolaus , Medicine-company-profile , Citigroup , Jpmorgan-chase-co , Investment-management , Vanguard-group-inc , Medicine-inc , Sumitomo-mitsui-trust-holdings-inc , Blackrock-inc , Prime-medicine , Free-report

Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $18.14

Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $18.14
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Stifel-nicolaus , Royal-bank , Medicine-inc , Citigroup , Ameritas-investment-partners-inc , Medicine-company-profile , Barclays-plc , Penserra-capital-management , Jpmorgan-chase-co , Life-insurance-co , Prime-medicine

Prime Medicine, Inc. (NYSE:PRME) Receives $18.14 Consensus Price Target from Brokerages

Prime Medicine, Inc. (NYSE:PRME) Receives $18.14 Consensus Price Target from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Ameritas-investment-partners-inc , Citigroup , Medicine-inc , Deutsche-bank , Life-insurance-co , Penserra-capital-management , Medicine-company-profile , Barclays-plc , Jpmorgan-chase-co , Prime-medicine , Get-free-report

Prime Medicine, Inc. (NYSE:PRME) Given Average Recommendation of "Moderate Buy" by Brokerages

Prime Medicine, Inc. (NYSE:PRME) Given Average Recommendation of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Penserra-capital-management , Jpmorgan-chase-co , Life-insurance-co , Ameritas-investment-partners-inc , Citigroup , Barclays-plc , Medicine-company-profile , Deutsche-bank , Medicine-inc , Prime-medicine , Get-free-report